4//SEC Filing
GRAHAM RICHARD A 4
Accession 0001415889-23-013342
CIK 0001583107other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 6:08 PM ET
Size
4.7 KB
Accession
0001415889-23-013342
Insider Transaction Report
Form 4
GRAHAM RICHARD A
SVP, Development
Transactions
- Sale
Ordinary Shares
2023-09-14$9.89/sh−2,482$24,547→ 336,803 total
Footnotes (1)
- [F1]This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001820036
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 6:08 PM ET
- Size
- 4.7 KB